https://www.pharmalive.com/wp-content/uploads/2020/07/Biogen-submits-U.S.-marketing-application-for-Alzheimers-disease-drug-Reuters-7-8-20.jpeg246369Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2020-10-21 14:50:482020-10-21 14:54:17Biogen to Halt Work on Opicinumab, Steer Focus Toward Parkinson’s Disease